Clinical Trial Update: Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3

View source ↗

Summary

This clinical trial update describes a study of Velmanase alfa (Lamzede) in children under 3 with Alpha-mannosidosis that is currently recruiting to assess its …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamzede (velmanase alfa)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Alpha-Mannosidosis | Status: RECRUITING